{"product_id":"digital-pcr-markets","title":"Digital PCR Markets 2027–2031","description":"\u003cp\u003e\u003cstrong\u003eDigital PCR Markets: Market Forecast, Competitive Landscape, Technology and World Metropolitan Area Market Sizes, 2027–2031\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGlobal forecasts of digital PCR supplier revenue by partitioning technology, product, application, end user and regulatory status, for 14 countries and regions and 237 metropolitan areas, with 36 company profiles. Droplet, nanoplate and chip-based systems, consumables, assays and software for research, biopharma QC, oncology, transplant, infectious disease and wastewater testing.\u003c\/p\u003e\n\u003cp\u003eSee the \u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/TECHDPCR_1126_Table_of_Contents.pdf?v=1793901291\" title=\"Digital PCR Markets Table of Contents\" target=\"_blank\" rel=\"noopener\"\u003eTable of Contents\u003c\/a\u003e. GET the \u003ca href=\"https:\/\/www.howesoundresearch.com\/pages\/get-a-detailed-table-of-contents-and-sample-pages-for-any-report\" title=\"Free sample\"\u003eFree Sample of this Report\u003c\/a\u003e.\u003c\/p\u003e\n\u003cp\u003eMany organizations subscribe to all or some of our reports. You may already have free access to this report. FIND out \u003ca href=\"https:\/\/www.howesoundresearch.com\/pages\/get-a-detailed-table-of-contents-and-sample-pages-for-any-report\" title=\"Contact Us\"\u003eHere\u003c\/a\u003e.\u003c\/p\u003e\n\u003ch3\u003eOur Take\u003c\/h3\u003e\n\u003cp\u003eDigital PCR counts molecules instead of estimating them, and that precision is taking the technology out of the research laboratory and into regulated work: release testing for cell and gene therapies, molecular residual disease, transplant monitoring and cleared diagnostic tests. Competition is moving from partition counts to workflow, validated assay menus and regulatory status. The market grows from $700.0 million in 2026 to $1,179.5 million in 2031, at 11.0% a year, and by 2031 regulated uses make up 48.0% of it.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/TECHDPCR_Key_Graphic.png?v=1793901291\" alt=\"Digital PCR goes regulated: digital PCR market size and mix, 2026–2031\" width=\"100%\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMarket Size 2026:\u003c\/strong\u003e USD $700.0M   \u003cstrong\u003eMarket Size 2031:\u003c\/strong\u003e USD $1,179.5M   \u003cstrong\u003eCAGR:\u003c\/strong\u003e 11.0%\u003c\/p\u003e\n\u003ch3\u003eSituation Analysis: what is really happening\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eResearch slows. \u003c\/strong\u003eLife Science Research is still the largest application at 33.0% of the market, but grows only 7.0% a year as academic funding weakens, falling to 27.5% by 2031.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiopharma QC and oncology lead. \u003c\/strong\u003eCell \u0026amp; Gene Therapy \u0026amp; Biopharma QC grows 15.1% a year and Oncology \u0026amp; Liquid Biopsy 13.9%; together they add 59% of all growth.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFrom research use only to GMP and IVD. \u003c\/strong\u003eCleared\/Certified IVD products grow 19.5% a year and GMP \u0026amp; Biopharma QC 16.7%, while Research Use Only falls from 62.0% to 52.0% of the market.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eKits pull through. \u003c\/strong\u003eAssays \u0026amp; Kits are the fastest-growing product line at 16.1% a year, while Instruments grow 7.4% as the installed base matures.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNew formats gain. \u003c\/strong\u003eChip \u0026amp; Other systems grow 20.0% a year, from 10.5% to 15.5% of the market, and Nanoplate \u0026amp; Microchamber Arrays rise from 33.5% to 37.0%.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNew owners. \u003c\/strong\u003eBio-Rad completed its acquisition of Stilla Technologies, Roche acquired SAGA Diagnostics, ARCHIMED completed its purchase of Biomark, and QIAGEN agreed to be taken private by EQT. China is the second-largest country market, at $91.2 million in 2026.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/TECHDPCR_Application_Shift.png?v=1793901291\" alt=\"Exact counts move to therapies: digital PCR market by application, 2026 vs 2031\" width=\"100%\"\u003e\u003c\/p\u003e\n\u003ch3\u003eCompany Analysis: who is positioned, who is exposed\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBio-Rad Laboratories, QIAGEN, Thermo Fisher Scientific and Roche Diagnostics: \u003c\/strong\u003eThe global platform makers, with HSR’s estimates of each company’s digital PCR revenue and ranges.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBeijing TargetingOne, Pilot Gene Technologies, Sinafu, RainSure Scientific and Maccura Biotechnology: \u003c\/strong\u003eChina’s digital PCR makers.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiomark Scientific, Countable Labs, Sysmex, BioTNS, Optolane Technologies, Bioneer, JN Medsys and PreciGenome: \u003c\/strong\u003eOther platform makers and emerging technologies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIntegrated DNA Technologies, LGC Biosearch Technologies, Horizon Discovery (Revvity), EntroGen, Gencurix, GT Molecular, Pxlence, ChromaCode and Hamilton Company: \u003c\/strong\u003eAssays, reference materials, kits and automation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFoundation Medicine’s SAGA Diagnostics, iMDx, Naveris (CareDx), Biodesix and Geneoscopy: \u003c\/strong\u003eClinical test developers using digital PCR.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCharles River Laboratories, Eurofins BioPharma Product Testing, CellCarta, GC Labs and WastewaterSCAN: \u003c\/strong\u003eTesting laboratories and public health programmes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIn all, 36 company profiles, each one to two pages with a fact box covering website, headquarters, ownership, revenue, employees and key products.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eInside the report:\u003c\/strong\u003e HSR’s revenue estimate for every named company, with low–high ranges, and a growth and share-change map of every application and technology line. Names and values are in the full report.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/TECHDPCR_Teaser_Company_Revenue.png?v=1793911395\" alt=\"Company revenue estimates, anonymised preview: names and values in the full report\" width=\"100%\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/TECHDPCR_Teaser_Segment_Map.png?v=1793911395\" alt=\"Growth and share-change map, anonymised preview: labels in the full report\" width=\"100%\"\u003e\u003c\/p\u003e\n\u003ch3\u003eQuestions this report answers\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eHow large is the digital PCR market, and how fast will it grow?\u003c\/li\u003e\n\u003cli\u003eHow much digital PCR revenue do Bio-Rad, QIAGEN, Thermo Fisher, Roche and China’s suppliers earn?\u003c\/li\u003e\n\u003cli\u003eHow fast are biopharma QC, oncology and transplant testing taking share from research?\u003c\/li\u003e\n\u003cli\u003eWhich partitioning technologies and product lines win as competition moves to workflow and regulatory status?\u003c\/li\u003e\n\u003cli\u003eWhat do IVDR, FDA clearances, NMPA approvals and GMP requirements mean for suppliers?\u003c\/li\u003e\n\u003cli\u003eHow large is each country market, and which metropolitan areas lead?\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhat's inside\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e382 pages, 23 chapters, 130 tables and 58 figures\u003c\/li\u003e\n\u003cli\u003eForecasts for 2027–2031 from a 2026 base year, by partitioning technology, product, application, end user and regulatory status, for 14 countries and regions\u003c\/li\u003e\n\u003cli\u003eMarket sizes for 237 world metropolitan areas in 2026 and 2031, with the top 30 and fastest-growing metros\u003c\/li\u003e\n\u003cli\u003eHow digital PCR works; partitioning technologies, products, applications and end users; technology trends; IVD – The Big Picture\u003c\/li\u003e\n\u003cli\u003eRegulation and quality; 10 market-moving developments; competitive landscape with company revenue estimates, SWOT, Porter's Five Forces and strategic recommendations\u003c\/li\u003e\n\u003cli\u003e36 company profiles\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/TECHDPCR_1126_Table_of_Contents.pdf?v=1793901291\" target=\"_blank\" rel=\"noopener\"\u003eDownload the Table of Contents (PDF)\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWho buys this report\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eInstrument and assay suppliers: \u003c\/strong\u003esize target segments by application, end user and regulatory status, and benchmark competitors.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiopharma and CDMOs: \u003c\/strong\u003eunderstand the tools for GMP release testing of cell and gene therapies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eClinical laboratories and test developers: \u003c\/strong\u003eplan MRD, liquid biopsy and transplant testing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInvestors: \u003c\/strong\u003eassess consolidation, take-privates and growth.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cb\u003eUse independent research that makes you the expert. Your credit card order sends the report to your inbox instantly. Check all your licensing options, but don't worry: your order is available as a credit if you wish to upgrade.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSee the \u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/TECHDPCR_1126_Table_of_Contents.pdf?v=1793901291\" title=\"Digital PCR Markets Table of Contents\" target=\"_blank\" rel=\"noopener\"\u003eTable of Contents\u003c\/a\u003e. GET the \u003ca href=\"https:\/\/www.howesoundresearch.com\/pages\/get-a-detailed-table-of-contents-and-sample-pages-for-any-report\" title=\"Free sample\"\u003eFree Sample of this Report\u003c\/a\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eABOUT THE LEAD AUTHOR\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cimg height=\"177\" width=\"142\" alt=\"Greg Powell\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/Powellcopy_480x480.png?v=1709168834\"\u003e\u003c\/p\u003e\n\u003cp\u003eMr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. His education includes:\u003c\/p\u003e\n\u003cp\u003eFinance for Senior Executives - \u003cstrong\u003eHarvard Business School\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMarket Research - \u003cstrong\u003eBurke Institute\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eM.B.A. (Finance and Policy) - \u003cstrong\u003eUniversity of British Columbia\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eB.Sc. (Chemistry) - \u003cstrong\u003eUniversity of British Columbia\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHe is an experienced business and clinical professional. He is co-author of the paper \"The Radioimmunoassay of Angiotensinogen by Antibody Trapping.\" He has worked in laboratory testing and management for over 20 years.\u003c\/p\u003e","brand":"Howe Sound Research","offers":[{"title":"Entire Report Single User","offer_id":68357110038641,"sku":null,"price":6995.0,"currency_code":"USD","in_stock":true},{"title":"Entire Report One to Five Users","offer_id":68357110071409,"sku":null,"price":9995.0,"currency_code":"USD","in_stock":true},{"title":"Entire Report Enterprise License","offer_id":68357110104177,"sku":null,"price":13995.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0249\/8082\/files\/TECHDPCR_1126_covercap.png?v=1793901291","url":"https:\/\/www.howesoundresearch.com\/products\/digital-pcr-markets","provider":"Howe Sound Research","version":"1.0","type":"link"}